P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trialsMarco Valgimigli, Roxana Mehran, Stephan Windecker et al.|BMJ|2021Cited by 254
Early versus Later Anticoagulation for Stroke with Atrial FibrillationUrs Fischer, Martina Göldlin, Masatoshi Koga et al.|New England Journal of Medicine|2023Cited by 217
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary InterventionsFelice Gragnano, Marco Valgimigli, Roxana Mehran et al.|Journal of the American College of Cardiology|2023Cited by 119
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trialUrs Fischer, Sven Trelle, Mattia Branca et al.|European Stroke Journal|2022Cited by 37
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)Hakim‐Moulay Dehbi, David J. Werring, Urs Fischer et al.|The Lancet|2025Cited by 33